Advanced ER+/HER2- breast cancer

Clinical trials for Advanced ER+/HER2- breast cancer explained in plain language.

Never miss a new study

Get alerted when new Advanced ER+/HER2- breast cancer trials appear

Sign up with your email to follow new studies for Advanced ER+/HER2- breast cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New hope for Hard-to-Treat breast cancer? early trial launches

Disease control Recruiting now

This study tests a new drug called QLS1304 combined with standard hormone therapy in people with advanced ER+/HER2- breast cancer whose disease has worsened after at least one prior hormone treatment. The trial has two phases: first finding the best dose, then checking how well i…

Matched conditions: ADVANCED ER+/HER2- BREAST CANCER

Phase 1/2 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 12:36 UTC

Advanced ER+/HER2- breast cancer

Get alerted when new Advanced ER+/HER2- breast cancer trials appear

New hope for Hard-to-Treat breast cancer? early trial launches